Drug profile

The FDA adverse-event record for Furosemide Tablets

51 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Furosemide Tablets. See the species affected, top reactions, and outcomes below.

51
adverse-event reports
7.8%
death-coded share
Unknown
most-reported species
15
Uncoded sign - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
51
Total Reports
4
Deaths Reported
7.8%
Death Rate

Active Ingredients

Furosemide Tablets

Administration Routes

UnknownOral

Species Affected

Unknown 31
Dog 19
Cat 1

Most Affected Breeds

Unknown 31
Chihuahua 4
Terrier - Yorkshire 4
Crossbred Canine/dog 2
Spitz - German Pomeranian 1
Terrier (unspecified) 1
Retriever - Labrador 1
Chin 1
Crossbred Feline/cat 1
Coton de Tuléar 1

Most Reported Reactions

Uncoded sign 15
Lot # and /or Expiration date missing 9
Lot # and/or Expiration date illegible 6
Physical product label issues 5
Lethargy (see also Central nervous system depression in 'Neurological') 4
Behavioural disorder NOS 4
Product label issues 4
Tablets, Abnormal 4
Polydipsia 4
Polyuria 4
Vomiting 3
Medication error 3

Outcome Breakdown

Outcome Unknown
5 (25.0%)
Recovered/Normal
5 (25.0%)
Ongoing
4 (20.0%)
Euthanized
3 (15.0%)
Recovered with Sequela
2 (10.0%)
Died
1 (5.0%)

Furosemide Tablets Adverse Event Insights

51 reports name Furosemide Tablets; 4 recorded a death outcome (7.8% of reported events, not a population-level mortality rate). Active ingredient: Furosemide Tablets. Administration routes: Unknown, Oral.

By species: Unknown (31 reports), Dog (19 reports), Cat (1 reports). By breed: Unknown (31), Chihuahua (4), Terrier - Yorkshire (4).

Leading clinical signs: Uncoded sign (15), Lot # and /or Expiration date missing (9), Lot # and/or Expiration date illegible (6), Physical product label issues (5). Outcome, 20 coded reports: Outcome Unknown leads at 25.0%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.